Drug Shortage Report for OXYTOCIN INJECTION, USP
Report ID | 95462 |
Drug Identification Number | 02139561 |
Brand name | OXYTOCIN INJECTION |
Common or Proper name | Oxytocin Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | OXYTOCIN |
Strength(s) | 10UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10mL |
ATC code | H01BB |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-10-04 |
Estimated end date | Unknown |
Actual end date | 2019-11-08 |
Shortage status | Resolved |
Updated date | 2019-11-28 |
Company comments | 10mL allocations have been reduced to 50% of historical 10mL demand. Customers with no historical 10mL demand will receive a limited allocation of 10mL vials to support the shortage of 1mL vials. Please note that this will be a one time allocation. The amount allocated will need to last customers until the end of November, there will be no more stock available of either size once you have purchased your one time allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-11-28 | French | Compare |
v4 | 2019-11-28 | English | Compare |
v3 | 2019-10-05 | English | Compare |
v2 | 2019-10-04 | French | Compare |
v1 | 2019-10-04 | English | Compare |
Showing 1 to 5 of 5